Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |